# A Based on PEEG and PET Study of Anxiolytic Treatment to Improve Cognitive Function in Patients With Alzheimer Disease

> **NCT03151382** · PHASE4 · UNKNOWN · sponsor: **Zhejiang Provincial People's Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Alzheimer Disease
- Cognitive Function

## Interventions

- **DRUG:** Tandospirone Citrate
- **DRUG:** Donepezil Hydrochloride

## Key facts

- **NCT ID:** NCT03151382
- **Lead sponsor:** Zhejiang Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-05-20
- **Primary completion:** 2017-12-31
- **Final completion:** 2018-06-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03151382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03151382, "A Based on PEEG and PET Study of Anxiolytic Treatment to Improve Cognitive Function in Patients With Alzheimer Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03151382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*